Infectious Disease

CLL

Questions discussed in this category

Do you routinely offer fungal prophylaxis for patients on BTK inhibitors?

Can experts comment on fungal pneumonia risk with individual BTK inhibitors as seen in ELEVATE-RR and whether this impacts their management decisions?

3 Answers available

Papers discussed in this category

J Clin Oncol, 2021 Jul 26

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.

Infectious Disease

CLL

Questions discussed in this category

Papers discussed in this category

Related Topics in Infectious Disease